Navigation Links
Avanir Pharmaceuticals Announces Appointment of Elona Kogan, Esq. as Vice President of Legal Affairs

ALISO VIEJO, Calif., May 9, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the appointment of Elona Kogan, Esq. to the position of vice president of legal affairs.

"At this time of growth and transition to a commercial stage biopharmaceutical company, Elona's legal, regulatory and business expertise will be a valuable asset to our organization," said Keith A. Katkin, president and CEO of Avanir. "The executive team and I are pleased to have Elona's extensive experience and expert counsel as we move ahead with our exciting new endeavors."

Ms. Kogan has over 17 years of experience covering areas of commercial and regulatory compliance, patient assistance programs, privacy issues, contracting, litigation and corporate governance. Most recently Ms. Kogan was associate general counsel and privacy officer at King Pharmaceuticals, where she was the primary legal liaison for corporate strategic and tactical commercial initiatives. Previously, Ms. Kogan was counsel for U.S. Medicines at Bristol-Myers Squibb. Prior roles included positions at Bergen Brunswig Corporation, and Epstein, Becker & Green. Ms. Kogan earned her J.D. degree from Southwestern University and her B.A. degree in Economics from Columbia University.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit

AVANIR™ is a trademark owned by Avanir Pharmaceuticals, Inc.

©2011 Avanir Pharmaceuticals, Inc. All Rights Reserved.

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Avanir Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference
2. Avanir Pharmaceuticals Announces Appointment of William Sibold as Chief Commercial Officer
3. Avanir Pharmaceuticals to Present Data at the American Academy of Neurology Annual Meeting
4. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
5. Avanir Pharmaceuticals to Present at Three Conferences in March
6. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
7. AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results
8. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
9. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
10. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
11. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from reveals that behind the tendency to set ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
Breaking Medicine News(10 mins):